نتائج البحث - "Anticholesteremic Agents administration & dosage"

المساهمون: Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Mer, molécules et santé EA 2160 (MMS), Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques, Université de Nantes (UN)-Université de Nantes (UN)-Le Mans Université (UM)-Université de Nantes - UFR des Sciences et des Techniques (UN UFR ST), Université de Nantes (UN)-Université de Nantes (UN), FR 3473 Institut universitaire Mer et Littoral (IUML), Le Mans Université (UM)-Université d'Angers (UA)-Université de Nantes (UN)-École Centrale de Nantes (ECN)-Université de Bretagne Sud (UBS)-Institut Français de Recherche pour l'Exploitation de la Mer (IFREMER)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche en Nutrition Humaine (CRNH), Centre hospitalier universitaire de Nantes (CHU Nantes), Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER, Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP), École pratique des hautes études (EPHE)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Le Mans Université (UM)-Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques, Université de Bretagne Sud (UBS)-Le Mans Université (UM)-Université d'Angers (UA)-Centre National de la Recherche Scientifique (CNRS)-Institut Français de Recherche pour l'Exploitation de la Mer (IFREMER)-Université de Nantes (UN)-École Centrale de Nantes (ECN), Centre René Gauducheau - ICO, institut de Cancerologie de l'Ouest, Le Mans Université (UM)-Université de Nantes - UFR des Sciences et des Techniques (UN UFR ST), Université de Nantes (UN)-Université de Nantes (UN)-Université de Nantes - UFR des Sciences Pharmaceutiques et Biologiques, Fumeron, Frédéric

المصدر: Nutrition Reviews
Nutrition Reviews, Oxford University Press (OUP), 2017, 75 (2), pp.134-145. ⟨10.1093/nutrit/nuw059⟩
Nutrition Reviews, 2017, 75 (2), pp.134-145. ⟨10.1093/nutrit/nuw059⟩

مصطلحات موضوعية: 0301 basic medicine, MESH: Anticholesteremic Agents/administration & dosage, [SDV]Life Sciences [q-bio], MESH: Plant Oils/chemistry, Medicine (miscellaneous), MESH: Dietary Supplements, MESH: Lipoproteins/genetics, MESH: Membrane Proteins/blood, MESH: Vegetables/chemistry, plant sterols, Intestinal absorption, chemistry.chemical_compound, Vegetables, cholesterol transporters, Nuts, LDL-cholesterol, genetics, Food science, ATP Binding Cassette Transporter, Subfamily G, Member 5, MESH: Lipoproteins/blood, Randomized Controlled Trials as Topic, MESH: Phytosterols/administration & dosage, Nutrition and Dietetics, Anticholesteremic Agents, intestinal absorption, Phytosterols, [SDV] Life Sciences [q-bio], Cholesterol, MESH: Apolipoproteins E/genetics, Biochemistry, MESH: ATP Binding Cassette Transporter, Subfamily G, Member 5/blood, lipids (amino acids, peptides, and proteins), MESH: ATP Binding Cassette Transporter, Subfamily G, Member 8/blood, MESH: Cholesterol/blood, Cholesterol synthesis, MESH: ATP Binding Cassette Transporter, Subfamily G, Member 5/genetics, MESH: ATP Binding Cassette Transporter, Subfamily G, Member 8/genetics, Lipoproteins, MESH: Fruit/chemistry, Biology, MESH: Membrane Proteins/genetics, 03 medical and health sciences, Apolipoproteins E, Meta-Analysis as Topic, MESH: Diet, MESH: Polymorphism, Genetic, Humans, Plant Oils, MESH: Meta-Analysis as Topic, Dietary supplementation, MESH: Apolipoproteins E/blood, MESH: Sitosterols/administration & dosage, Cholesterol absorption, Polymorphism, Genetic, MESH: Humans, 030109 nutrition & dietetics, MESH: Nuts/chemistry, ATP Binding Cassette Transporter, Subfamily G, Member 8, Membrane Proteins, Membrane Transport Proteins, Cholesterol lowering, MESH: Edible Grain/chemistry, Sitosterols, Diet, [SDV.AEN] Life Sciences [q-bio]/Food and Nutrition, MESH: Randomized Controlled Trials as Topic, chemistry, Plant stanol ester, Fruit, Dietary Supplements, Edible Grain, individual response, [SDV.AEN]Life Sciences [q-bio]/Food and Nutrition, Plant sterols

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7399a11f3b28041bb5609336f79bd336
https://doi.org/10.1093/nutrit/nuw059

6

Defining the Place of Ezetimibe/Atorvastatin in the Management of Hyperlipidemia

المؤلفون: António Miguel Ferreira, Pedro Marques da Silva

المصدر: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP

مصطلحات موضوعية: Oncology, Simvastatin, medicine.medical_specialty, Statin, Combination therapy, HSM MED, medicine.drug_class, Atorvastatin, Drug Therapy, Combination/methods, Hyperlipidemias, 030204 cardiovascular system & hematology, Simvastatin/administration & dosage, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Ezetimibe, Anticholesteremic Agents/administration & dosage, Internal medicine, Ezetimibe/atorvastatin, Hyperlipidemia, medicine, Humans, Pharmacology (medical), Atorvastatin Calcium/administration & dosage, cardiovascular diseases, 030212 general & internal medicine, Cholesterol, HDL/blood, Hyperlipidemias/drug therapy, Cholesterol, business.industry, Anticholesteremic Agents, Ezetimibe/administration & dosage, Cholesterol, HDL, Hyperlipidemias/blood, nutritional and metabolic diseases, Cholesterol, LDL, General Medicine, medicine.disease, Endocrinology, Cholesterol, LDL/blood, chemistry, Drug Therapy, Combination, lipids (amino acids, peptides, and proteins), Cardiology and Cardiovascular Medicine, business, Dyslipidemia, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78574ec99fb753c1dab963652728f558
https://doi.org/10.1007/s40256-016-0205-0

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

7

دورية أكاديمية

Le medicament du mois. Ezetimibe (Ezetrol).
Ezetimibe (Ezetrol)

المؤلفون: Scheen, André

المصدر: Revue Médicale de Liège, 59 (4), 246-50 (2004)

مصطلحات موضوعية: Anticholesteremic Agents/administration & dosage/adverse effects/therapeutic use, Azetidines/administration & dosage/adverse effects/therapeutic use, Cardiovascular Diseases/etiology/prevention & control, Cholesterol/metabolism, Drug Therapy, Combination, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Hypercholesterolemia/diet therapy/drug therapy/genetics, Phytosterols/metabolism, Treatment Outcome, Human health sciences, Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Pharmacie, pharmacologie & toxicologie

Relation: http://www.rmlg.ulg.ac.be; urn:issn:0370-629X; urn:issn:2566-1566

URL الوصول: https://orbi.uliege.be/handle/2268/10262

8

Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes

المؤلفون: Nicolas Rodondi, Dik Heg, Thomas F. Lüscher, François Mach, Stephan Windecker, Christian M. Matter, Lorenz Räber, Alexios Karagiannis, David Carballo, David Nanchen, Baris Gencer, Sebastian Carballo, Konstantinos C. Koskinas, Roland Klingenberg, Reto Auer

المساهمون: University of Zurich, Gencer, Baris

المصدر: Journal of the American Heart Association, vol. 6, no. 11, pp. NA
Gencer, Baris; Koskinas, Konstantinos C; Räber, Lorenz; Karagiannis, Alexios; Nanchen, David; Auer, Reto; Carballo, David; Carballo, Sebastian; Klingenberg, Roland; Heg, Dik; Matter, Christian M; Lüscher, Thomas F; Rodondi, Nicolas; Mach, François; Windecker, Stephan (2017). Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes. Journal of the American Heart Association, 6(11), e006537. American Heart Association 10.1161/JAHA.117.006537 <http://dx.doi.org/10.1161/JAHA.117.006537>
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

مصطلحات موضوعية: Male, Time Factors, Treatment outcome, Myocardial Infarction, Eligibility Determination, Apoptosis, 030204 cardiovascular system & hematology, PCSK9, 0302 clinical medicine, Medicine, Prospective Studies, 030212 general & internal medicine, Preventive Cardiology, PCSK9 Inhibitors, Societies, Medical, Original Research, Secondary prevention, Lipids and Cholesterol, Anticholesteremic Agents, Follow up studies, Acute Coronary Syndrome/blood, Acute Coronary Syndrome/drug therapy, Anticholesteremic Agents/administration & dosage, Cardiology, Cholesterol, LDL/blood, Dose-Response Relationship, Drug, Eligibility Determination/methods, Europe, Ezetimibe/administration & dosage, Female, Follow-Up Studies, Humans, Middle Aged, Practice Guidelines as Topic, Proprotein Convertase 9/antagonists & inhibitors, Treatment Outcome, United States, lipids, secondary prevention, 3. Good health, 10209 Clinic for Cardiology, lipids (amino acids, peptides, and proteins), Cardiology and Cardiovascular Medicine, medicine.medical_specialty, 610 Medicine & health, 2705 Cardiology and Cardiovascular Medicine, 03 medical and health sciences, 360 Social problems & social services, Internal medicine, Acute Coronary Syndrome, Proprotein, business.industry, Cholesterol, LDL, Ezetimibe, European atherosclerosis society, business

وصف الملف: application/pdf; ZORA149776.pdf - application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c6bde8c190ad0be7269ef60837924bd
https://serval.unil.ch/resource/serval:BIB_6ADD45556097.P001/REF.pdf

9

Evaluation of antiatherogenic properties of ezetimibe using 3H-labeled low-density-lipoprotein cholesterol and 99mTc-cAbVCAM1-5 sPECT in ApoE2/2 mice fed the paigen diet

المؤلفون: Dumas, Laurent S, Briand, François, Clerc, Romain, Brousseau, Emmanuel, Montemagno, Christopher, Ahmadi, Mitra, Bacot, Sandrine, Soubies, Audrey, Perret, Pascale, Riou, Laurent M, Devoogdt, Nick, Lahoutte, Tony, Baronne-Rochette, Gilles, Fagret, Daniel, Ghezzi, Catherine, Sulpice, Thierry, Broisat, Alexis

المساهمون: Translational Imaging Research Alliance, Medical Imaging, Supporting clinical sciences

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3848::0410987423f94bee7b7aaa5e1f41f46c
https://doi.org/10.2967/jnumed.116.177279

10

Antihypertensive treatment with β-blockade in patients with asymptomatic aortic stenosis and association with cardiovascular events

المؤلفون: Kurt Boman, Kristian Wachtell, Richard B. Devereux, Kenneth Egstrup, Simon Ray, Anders M. Greve, Christoph A. Nienaber, Casper N. Bang, Anne B. Rossebø, Peter M. Okin

المصدر: Bang, C N, Greve, A M, Rossebø, A B, Ray, S, Egstrup, K, Boman, K, Nienaber, C, Okin, P M, Devereux, R B & Wachtell, K 2017, ' Antihypertensive treatment with β-blockade in patients with asymptomatic aortic stenosis and association with cardiovascular events ', Journal of the American Heart Association, vol. 6, no. 12, e006709 . https://doi.org/10.1161/JAHA.117.006709
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

مصطلحات موضوعية: Male, Simvastatin, Aortic Valve Stenosis/complications, Blood Pressure, aortic valve stenosis, 030204 cardiovascular system & hematology, Arrhythmias, Heart Ventricles/diagnostic imaging, Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage, 0302 clinical medicine, High blood pressure, Cause of Death, Anticholesteremic Agents/administration & dosage, Adrenergic beta-1 Receptor Antagonists/administration & dosage, Arrhythmia and Electrophysiology, atrial fibrillation, Cardiac and Cardiovascular Systems, 030212 general & internal medicine, Depression (differential diagnoses), Original Research, Aged, 80 and over, Survival Rate/trends, Kardiologi, Anticholesteremic Agents, Hypertension/drug therapy, Atrial fibrillation, Middle Aged, United States/epidemiology, Adrenergic beta-1 Receptor Antagonists, Echocardiography, Doppler, Survival Rate, Aortic valve stenosis, Cardiology, beta-blocker, Female, Morbidity/trends, Drug Therapy, Combination, medicine.symptom, Cardiology and Cardiovascular Medicine, Echocardiography, Doppler/methods, arrhythmia (heart rhythm disorders), medicine.medical_specialty, hypertension, Heart Ventricles, Cause of Death/trends, Asymptomatic, Simvastatin/administration & dosage, β‐blocker, Blood Pressure/drug effects, β blockade, 03 medical and health sciences, Double-Blind Method, Internal medicine, medicine, high blood essure, Humans, In patient, Propensity Score, Aged, B-blocker, Dose-Response Relationship, Drug, business.industry, Ezetimibe/administration & dosage, medicine.disease, Ezetimibe, United States, Stenosis, Concomitant, Valvular Heart Disease, Asymptomatic Diseases, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Morbidity, business, high blood pressure

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::595529e17fdd4235a7174ff5de07807d
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-144421

تنقيح النتائج